Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation

Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation

Bibliographic Details
Main Author:	Morris Kletzel
Format:	Article
Language:	English
Published:	Elsevier 2013-01-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000500309&lng=en&tlng=en

Similar Items

Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
by: Alberto Olaya Vargas, et al.
Published: (2013-01-01)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
by: Erden Atilla, et al.
Published: (2017-02-01)

Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
by: Azulamara da Silva Ruiz, et al.

Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
by: Zeynep Arzu Yegin, et al.
Published: (2020-12-01)

Supplementation with Oral Vitamin C Prior to and during Myeloablative Chemotherapy and Autologous Haematopoietic Stem Cell Transplantation: A Pilot Study
by: Anitra C. Carr, et al.
Published: (2022-09-01)

Patients Undergoing Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation Exhibit Depleted Vitamin C Status in Association with Febrile Neutropenia
by: Anitra C. Carr, et al.
Published: (2020-06-01)

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
by: Michael M. B. Green, et al.
Published: (2016-08-01)

The effectiveness of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in the treatment
by: T. V. Yukhta, et al.
Published: (2019-12-01)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
by: Xing-yu Cao, et al.
Published: (2023-12-01)

Hematopoietic progenitor cell mobilization for autologous transplantation - a literature review
by: Marco Aurélio Salvino, et al.
Published: (2016-02-01)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
by: José Francisco Comenalli Marques Jr
Published: (2011-12-01)

Total Marrow and Lymphoid Irradiation: A New Technology Assisting in Myeloablating Before Hematopoietic Stem Cell Transplantation
by: SHEN Jing, et al.
Published: (2023-07-01)

Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome.
by: Yang Jo Chung, et al.
Published: (2017-01-01)

Autologous hematopoietic stem cell transplantation in remission consolidation of acute myeloid leukemia with initially unfavorable prognostic factors
by: G. D. Petrova, et al.
Published: (2016-03-01)

Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
by: Longfei Gao, et al.
Published: (2021-08-01)

Feasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol
by: Raita Araki, et al.
Published: (2018-06-01)

Autologous hematopoietic stem cell transplantation for systemic scleroderma
by: R T Alekperov, et al.
Published: (2012-08-01)

Allogeneic hematopoietic stem cell transplantation with the modified myeloablative conditioning regimen for children with chronic active Epstein–Barr virus infection
by: Yanhui Luo, et al.
Published: (2022-12-01)

Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells.
by: Thomas Walenda, et al.
Published: (2011-01-01)

Autologous Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Lymphoma
by: Babak Bahar, et al.
Published: (2012-07-01)

Autologous hematopoietic stem cell transplantation for refractory Crohn's disease
by: Antonio Giordano, et al.
Published: (2022-10-01)

Autologous Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Lymphoma
by: Fatemeh Ghaffari, et al.
Published: (2012-09-01)

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
by: Nicoletta Del Papa, et al.
Published: (2018-10-01)

Autologous transplant: microbial contamination of hematopoietic stem cell products
by: Igor Dullius Almeida, et al.

SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
by: Sandra Fernandes, et al.
Published: (2015-03-01)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
by: Afonso José Pereira Cortez, et al.
Published: (2011-02-01)

Optimizing autologous hematopoietic stem cell transplantation for acute leukemia
by: Aiming Pang, et al.
Published: (2021-11-01)

Herpes zoster after autologous hematopoietic stem cell transplantation
by: Kelli Borges dos Santos, et al.

Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations
by: Anna S. Świerzko, et al.
Published: (2020-01-01)

Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Mohammad Jahani, et al.
Published: (2011-01-01)

Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Ardeshir Ghavamzadeh, et al.
Published: (2011-03-01)

Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease
by: Emily Limerick, et al.
Published: (2022-07-01)

Use of high-dosage chemotherapy with autologous hematopoietic stem cell transplantation as a first-line therapy for the patients with poor-prognosis testicular tumors
by: Marjanović Slobodan, et al.
Published: (2005-01-01)

Comment on: Bacteremia in pediatric patients with hematopoietic stem transplantation
by: Antonio Vaz de Macedo
Published: (2020-01-01)

Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
by: Mackinnon, S, et al.
Published: (1999)

Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation
by: Edina Poletto, et al.
Published: (2022-06-01)

Autologous hematopoietic stem cell transplant in pediatric lymphoma our experience
by: Pranoti Chiwarkar, et al.
Published: (2022-01-01)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
by: Jennifer C. Massey, et al.
Published: (2018-03-01)

Reactivation of Chagas disease after autologous hematopoietic stem cell transplantation
by: Claudia Marcela Chalela, et al.
Published: (2020-12-01)

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
by: Awadh Kishor Pandit, et al.
Published: (2015-01-01)